Document is current
Any future updates will be listed below
-
Authors
Matsuda, Satoru
Kitagawa, Yuko
Kawakubo, Hirofumi
Okui, Jun
Okamura, Akihiko
Takemura, Ryo
Muto, Manabu
Kakeji, Yoshihiro
Takeuchi, Hiroya
Watanabe, Masayuki
Doki, Yuichiro
- License Information
-
More Information
Article History
Received: 10 June 2022
Accepted: 3 October 2022
First Online: 1 November 2022
Declarations
:
: Yuko Kitagawa received research grants from Takeda Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd., Yakult Honsha Co. Ltd., Asahi Kasei Pharma Corporation, Otsuka Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Tsumura & Co., Kyouwa Hakkou Kirin Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., EA Pharma Co., Ltd., Medicon Inc., Kaken Pharmaceutical Co. Ltd., Eisai Co., Ltd., Otsuka Pharmaceutical Factory Inc., Teijin Pharma Limited., Nihon Pharmaceutical Co., Ltd., Nippon Covidien Inc.. Yuko Kitagawa received lecture fees / honoraria from Chugai Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd., Asahi Kasei Pharma Corporation, Otsuka Pharmaceutical Factory Inc., Shionogi & Co., Ltd., Nippon Covidien Inc., Ethicon, Inc., Ono Pharmaceutical Co., Ltd., Olympus Corporation, Bristol-Myers Squibb K.K., AstraZeneca K.K., MSD K.K., Smith & Nephew KK, Kaken Pharmaceutical Co., Ltd., ASKA Pharmaceutical Co., Ltd., Miyarisan Pharmaceutical Co., Ltd.
: This study was approved by the Ethics Committee of the Keio University School of Medicine and by all participating esophageal centers.
